About Drupal 8
Have you ever felt that your website needs to be more personalized, integrated with cutting-edge technology to offer enhanced user experience?
Valuebound is one of those companies, which specifically help organizations in their path to digital transformation. We enhance digital experience for end users with tailored web applications.
Recent releases
|
Top Benefits of AWS for Healthcare Organizations
Introduction
A. Overview of AWS in the healthcare sector
In an era where technology plays a pivotal role in healthcare, Amazon Web Services (AWS) emerges as a transformative…
|
Top 14 Benefits of AWS for E-commerce Businesses
Introduction
In the ever-evolving landscape of e-commerce, businesses are constantly seeking ways to enhance their operations, improve customer experiences, and stay ahead of the competition. One…
|
Top 9 Benefits of AWS for Startups
Introduction
In the dynamic landscape of startups, innovation is the key to success. Amazon Web Services (AWS) offers a robust cloud platform that empowers startups to unleash their creativity,…
|
Choosing the Best Drupal Migration Company: Your Complete Guide
Drupal migration can be a complex process, especially if you are not familiar with the platform. It involves transferring your website from an older version of Drupal to a newer one. This can be a…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
